CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.

Ramon G Manzano; Luis M Montuenga; Mark Dayton; Paul Dent; Ichiro Kinoshita; Silvestre Vicent; Ginger J Gardner; PhuongMai Nguyen; Yung-Hyun Choi; Jane Trepel

doi:10.1038/sj.onc.1205542

CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.

Identifier:nobleid.org/w1/20260515/FBDDF861

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FBDDF861.svg?ark=w1%2F20260515%2FFBDDF861)](https://nobleid.org/work/w1/20260515/FBDDF861)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.

Identifier:nobleid.org/w1/20260515/FBDDF861

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FBDDF861.svg?ark=w1%2F20260515%2FFBDDF861)](https://nobleid.org/work/w1/20260515/FBDDF861)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work